Congressman Brian Fitzpatrick (PA-1) has announced the passage of the Joe Fiandra Access to Home Infusion Act of 2025, a bipartisan measure that expands Medicare coverage for home infusion therapy. The legislation, named after Army veteran and Pennsylvania resident Joe Fiandra, was included in the Consolidated Appropriations Act of 2026.
Joe Fiandra, who died in 2022 after battling amyloidosis, encountered significant obstacles in accessing necessary home-based infusion treatment. The new law addresses gaps in Medicare coverage by ensuring that external infusion pumps and certain drugs administered by health professionals at home are classified as Durable Medical Equipment (DME). This change is expected to benefit seniors nationwide who require complex or frequent infusion therapies at home.
Helen Fiandra, Joe’s wife and Warrington resident, said: “Joe faced his illness with the same courage that defined his life, but the barriers he encountered made an already difficult battle even harder. With this bill becoming law, no family will have to endure those same struggles—and that brings us peace, and profound pride in Joe’s legacy. I am deeply grateful to Congressman Fitzpatrick for standing with us from the beginning, listening to our story, and turning it into action. Having this legislation bear Joe’s name is an honor. It means his fight will spare other families from suffering, and his life will continue to make a difference for years to come.”
Fitzpatrick stated: “Joe Fiandra served our nation with honor, loved his family fiercely, and faced his illness with courage. But his fight revealed a health care system that made an already difficult moment even harder. When I met with Joe’s wife, Helen, she asked for one thing—that no other family would have to endure the same struggle. Now, with the signing of this bill, that promise has become law. Joe Fiandra’s legacy will permanently strengthen how Medicare delivers care—putting patients first and removing barriers that never should have existed. I am grateful to Helen for her strength, her partnership, and her advocacy, and will continue working to ensure our health care system does what it exists to do—help people when they need it most.”
In 2020, federal regulators acknowledged problems in existing Medicare policy regarding coverage for home infusion drugs requiring professional supervision but did not finalize changes at that time. The new law now closes this gap by amending the Social Security Act so that these treatments are covered as DME under specific conditions: if administration requires a health professional according to FDA-approved instructions; if performed at home by a qualified supplier; and if frequent administration or special equipment like external pumps are needed.
The act also introduces transparency requirements for patient cost-sharing obligations related to home infusion therapy compared with other care settings.
The Amyloidosis Support Group supports the act as part of broader efforts toward patient-centered Medicare policy.
Brian Fitzpatrick has represented Pennsylvania’s 1st district in Congress since 2017 after replacing Mike Fitzpatrick. He was born in Philadelphia in 1973 and currently resides in Levittown. Fitzpatrick holds degrees from La Salle University (BS) and Pennsylvania State University (JD).
###
